NORCROSS, Ga., Feb. 26, 2026 (GLOBE NEWSWIRE) -- Galectin Therapeutics Inc. (NASDAQ:GALT), the leading developer of galectin-3-targeted therapeutics for patients with MASH cirrhosis and portal ...
A physician who specializes in HIV treatment writes that proposed cuts to an AIDS drug program proposed by the Florida Dept.
Scaling back Florida’s AIDS Drug Assistance Program could mean a resurgence of HIV/AIDS and increased health care costs ...
HER2-positive gastric cancer accounts for a substantial proportion of advanced cases and has long been treated with HER2-targeted therapies. While trastuzumab deruxtecan has shown superior activity ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results